ID   TITIN_HUMAN             Reviewed;        5604 AA.
AC   Q8WZ42-6;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 4.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=Isoform 6 of Titin;
DE            EC=2.7.11.1;
DE   AltName: Full=Connectin;
DE   AltName: Full=Rhabdomyosarcoma antigen MU-RMS-40.14;
GN   Name=TTN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   3336-12202 (ISOFORM 4), AND VARIANTS ILE-498; GLU-1201; MET-3261; ASN-3419;
RP   SER-3491; GLU-12679; ILE-19762; ILE-20718; ASN-23807; MET-24980 AND
RP   THR-27755.
RC   TISSUE=Skeletal muscle;
RX   PubMed=7569978; DOI=10.1126/science.270.5234.293;
RA   Labeit S., Kolmerer B.;
RT   "Titins, giant proteins in charge of muscle ultrastructure and
RT   elasticity.";
RL   Science 270:293-296(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS
RP   LEU-1295; GLN-1572; ILE-2610; ASN-2831; SER-3491; PRO-4215; PHE-4283 AND
RP   ARG-12383.
RX   PubMed=10850961; DOI=10.1161/01.res.86.11.1114;
RA   Freiburg A., Trombitas K., Hell W., Cazorla O., Fougerousse F., Centner T.,
RA   Kolmerer B., Witt C., Beckmann J.S., Gregorio C.C., Granzier H., Labeit S.;
RT   "Series of exon-skipping events in the elastic spring region of titin as
RT   the structural basis for myofibrillar elastic diversity.";
RL   Circ. Res. 86:1114-1121(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, INTERACTION WITH OBSCN, AND VARIANTS LEU-1295; GLN-1572;
RP   ILE-2610; ASN-2831; SER-3491; PRO-4215 AND PHE-4283.
RX   PubMed=11717165; DOI=10.1161/hh2301.100981;
RA   Bang M.-L., Centner T., Fornoff F., Geach A.J., Gotthardt M., McNabb M.,
RA   Witt C.C., Labeit D., Gregorio C.C., Granzier H., Labeit S.;
RT   "The complete gene sequence of titin, expression of an unusual ~700 kDa
RT   titin isoform and its interaction with obscurin identify a novel Z-line to
RT   I-band linking system.";
RL   Circ. Res. 89:1065-1072(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-626 AND 34071-34350 (ISOFORM
RP   3).
RC   TISSUE=Muscle, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 405-709 (ISOFORMS 1 AND 2).
RC   TISSUE=Heart muscle;
RX   PubMed=8937992; DOI=10.1242/jcs.109.11.2747;
RA   Gautel M., Goulding D., Bullard B., Weber K., Furst D.O.;
RT   "The central Z-disk region of titin is assembled from a novel repeat in
RT   variable copy numbers.";
RL   J. Cell Sci. 109:2747-2754(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2023-2060, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart muscle;
RX   PubMed=7819249; DOI=10.1021/bi00002a021;
RA   Musco G., Tziatzos C., Schuck P., Pastore A.;
RT   "Dissecting titin into its structural motifs: identification of an alpha
RT   helix near the N-terminus.";
RL   Biochemistry 34:553-561(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3455-4473, AND VARIANTS PRO-4215 AND
RP   PHE-4283.
RX   PubMed=10051295; DOI=10.1161/01.cir.99.8.1022;
RA   Siu B.L., Niimura H., Osborne J.A., Fatkin D., MacRae C., Solomon S.,
RA   Benson D.W., Seidman J.G., Seidman C.E.;
RT   "Familial dilated cardiomyopathy locus maps to chromosome 2q31.";
RL   Circulation 99:1022-1026(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9806-12017 (ISOFORM 5).
RC   TISSUE=Heart ventricle;
RX   PubMed=12785098; DOI=10.1023/a:1023410523184;
RA   Greaser M.L., Berri M., Warren C.M., Mozdziak P.E.;
RT   "Species variations in cDNA sequence and exon splicing patterns in the
RT   extensible I-band region of cardiac titin: relation to passive tension.";
RL   J. Muscle Res. Cell Motil. 23:473-482(2002).
RN   [10]
RP   PROTEIN SEQUENCE OF 11773-11783; 17908-17931; 18656-18669; 26545-26553;
RP   28758-28774 AND 32920-32928, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12947-13797.
RC   TISSUE=Embryonic rhabdomyosarcoma;
RA   Behrends U., Gotz C., Mautner J.;
RT   "Serological identification of rhabdomyosarcoma antigens.";
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 14257-14543.
RX   PubMed=8351016; DOI=10.1212/wnl.43.8.1581;
RA   Gautel M., Lakey A., Barlow D.P., Holmes Z., Scales S., Leonard K.,
RA   Labeit S., Mygland A., Gilhus N.E., Aarli J.A.;
RT   "Titin antibodies in myasthenia gravis: identification of a major
RT   immunogenic region of titin.";
RL   Neurology 43:1581-1585(1993).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21021-22120, AND NUCLEOTIDE SEQUENCE [GENOMIC
RP   DNA] OF 23754-24284.
RX   PubMed=1582406; DOI=10.1002/j.1460-2075.1992.tb05222.x;
RA   Labeit S., Gautel M., Lakey A., Trinick J.;
RT   "Towards a molecular understanding of titin.";
RL   EMBO J. 11:1711-1716(1992).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29701-34350, AND PHOSPHORYLATION.
RX   PubMed=8404852; DOI=10.1002/j.1460-2075.1993.tb06061.x;
RA   Gautel M., Leonard K., Labeit S.;
RT   "Phosphorylation of KSF motifs in the C-terminal region of titin in
RT   differentiating myoblasts.";
RL   EMBO J. 12:3827-3834(1993).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33119-34350.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [16]
RP   INTERACTION WITH TCAP.
RX   PubMed=9645487; DOI=10.1016/s0014-5793(98)00501-8;
RA   Mues A., van der Ven P.F.M., Young P., Furst D.O., Gautel M.;
RT   "Two immunoglobulin-like domains of the Z-disc portion of titin interact in
RT   a conformation-dependent way with telethonin.";
RL   FEBS Lett. 428:111-114(1998).
RN   [17]
RP   INTERACTION WITH NEB.
RX   PubMed=12482578; DOI=10.1016/s0014-5793(02)03655-4;
RA   Ma K., Wang K.;
RT   "Interaction of nebulin SH3 domain with titin PEVK and myopalladin:
RT   implications for the signaling and assembly role of titin and nebulin.";
RL   FEBS Lett. 532:273-278(2002).
RN   [18]
RP   INTERACTION WITH FHL2.
RX   PubMed=12432079; DOI=10.1242/jcs.00181;
RA   Lange S., Auerbach D., McLoughlin P., Perriard E., Schafer B.W.,
RA   Perriard J.-C., Ehler E.;
RT   "Subcellular targeting of metabolic enzymes to titin in heart muscle may be
RT   mediated by DRAL/FHL-2.";
RL   J. Cell Sci. 115:4925-4936(2002).
RN   [19]
RP   INTERACTION WITH ANK1.
RX   PubMed=12444090; DOI=10.1074/jbc.m209012200;
RA   Kontrogianni-Konstantopoulos A., Bloch R.J.;
RT   "The hydrophilic domain of small ankyrin-1 interacts with the two N-
RT   terminal immunoglobulin domains of titin.";
RL   J. Biol. Chem. 278:3985-3991(2003).
RN   [20]
RP   INTERACTION WITH ANKRD1; ANKRD2; ANKRD23 AND CAPN3.
RX   PubMed=14583192; DOI=10.1016/j.jmb.2003.09.012;
RA   Miller M.K., Bang M.-L., Witt C.C., Labeit D., Trombitas C., Watanabe K.,
RA   Granzier H., McElhinny A.S., Gregorio C.C., Labeit S.;
RT   "The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family
RT   of titin filament-based stress response molecules.";
RL   J. Mol. Biol. 333:951-964(2003).
RN   [21]
RP   INTERACTION WITH CRYAB.
RX   PubMed=14676215; DOI=10.1074/jbc.m307473200;
RA   Bullard B., Ferguson C., Minajeva A., Leake M.C., Gautel M., Labeit D.,
RA   Ding L., Labeit S., Horwitz J., Leonard K.R., Linke W.A.;
RT   "Association of the chaperone alphaB-crystallin with titin in heart
RT   muscle.";
RL   J. Biol. Chem. 279:7917-7924(2004).
RN   [22]
RP   INTERACTION WITH TRIM63 AND TRIM55.
RX   PubMed=15967462; DOI=10.1016/j.jmb.2005.05.021;
RA   Witt S.H., Granzier H., Witt C.C., Labeit S.;
RT   "MURF-1 and MURF-2 target a specific subset of myofibrillar proteins
RT   redundantly: towards understanding MURF-dependent muscle ubiquitination.";
RL   J. Mol. Biol. 350:713-722(2005).
RN   [23]
RP   INTERACTION WITH LAMIN, AND SUBCELLULAR LOCATION.
RX   PubMed=16410549; DOI=10.1242/jcs.02728;
RA   Zastrow M.S., Flaherty D.B., Benian G.M., Wilson K.L.;
RT   "Nuclear titin interacts with A- and B-type lamins in vitro and in vivo.";
RL   J. Cell Sci. 119:239-249(2006).
RN   [24]
RP   REVIEW.
RX   PubMed=16537787; DOI=10.1152/ajpheart.00816.2005;
RA   Hoshijima M.;
RT   "Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk,
RT   titin, and associated structures.";
RL   Am. J. Physiol. 290:H1313-H1325(2006).
RN   [25]
RP   INTERACTION WITH CMYA5.
RX   PubMed=20634290; DOI=10.1074/jbc.m110.108720;
RA   Sarparanta J., Blandin G., Charton K., Vihola A., Marchand S., Milic A.,
RA   Hackman P., Ehler E., Richard I., Udd B.;
RT   "Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to
RT   tibial and limb-girdle muscular dystrophies.";
RL   J. Biol. Chem. 285:30304-30315(2010).
RN   [26]
RP   STRUCTURE BY NMR OF 33483-33579.
RX   PubMed=7613868; DOI=10.1016/s0969-2126(01)00170-8;
RA   Pfuhl M., Pastore A.;
RT   "Tertiary structure of an immunoglobulin-like domain from the giant muscle
RT   protein titin: a new member of the I set.";
RL   Structure 3:391-401(1995).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 32172-32489, FUNCTION, ACTIVITY
RP   REGULATION, INTERACTION WITH CALM, PHOSPHORYLATION AT TYR-32341, AND
RP   MUTAGENESIS OF LYS-32207 AND TYR-32341.
RX   PubMed=9804419; DOI=10.1038/27603;
RA   Mayans O., van der Ven P.F.M., Wilm M., Mues A., Young P., Furst D.O.,
RA   Wilmanns M., Gautel M.;
RT   "Structural basis for activation of the titin kinase domain during
RT   myofibrillogenesis.";
RL   Nature 395:863-869(1998).
RN   [28]
RP   STRUCTURE BY NMR OF 22283-22385.
RX   PubMed=9782056; DOI=10.1016/s0969-2126(98)00129-4;
RA   Goll C.M., Pastore A., Nilges M.;
RT   "The three-dimensional structure of a type I module from titin: a prototype
RT   of intracellular fibronectin type III domains.";
RL   Structure 6:1291-1302(1998).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 2073-2171, AND DISULFIDE BOND.
RX   PubMed=11525170; DOI=10.1016/s0969-2126(01)00591-3;
RA   Mayans O., Wuerges J., Canela S., Gautel M., Wilmanns M.;
RT   "Structural evidence for a possible role of reversible disulphide bridge
RT   formation in the elasticity of the muscle protein titin.";
RL   Structure 9:331-340(2001).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.44 ANGSTROMS) OF 1-196 IN COMPLEX WITH TCAP.
RX   PubMed=16407954; DOI=10.1038/nature04343;
RA   Zou P., Pinotsis N., Lange S., Song Y.-H., Popov A., Mavridis I.,
RA   Mayans O.M., Gautel M., Wilmanns M.;
RT   "Palindromic assembly of the giant muscle protein titin in the sarcomeric
RT   Z-disk.";
RL   Nature 439:229-233(2006).
RN   [31]
RP   VARIANT CMH9 LEU-740.
RX   PubMed=10462489; DOI=10.1006/bbrc.1999.1221;
RA   Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., Kimura A.;
RT   "Structural analysis of the titin gene in hypertrophic cardiomyopathy:
RT   identification of a novel disease gene.";
RL   Biochem. Biophys. Res. Commun. 262:411-417(1999).
RN   [32]
RP   INVOLVEMENT IN LGMDR10, AND VARIANT TMD PRO-34315.
RX   PubMed=12145747; DOI=10.1086/342380;
RA   Hackman P., Vihola A., Haravuori H., Marchand S., Sarparanta J.,
RA   De Seze J., Labeit S., Witt C., Peltonen L., Richard I., Udd B.;
RT   "Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the
RT   gene encoding the giant skeletal-muscle protein titin.";
RL   Am. J. Hum. Genet. 71:492-500(2002).
RN   [33]
RP   VARIANTS CMD1G MET-54; VAL-743; TYR-3799 AND ASN-4465, VARIANTS CYS-328;
RP   GLN-4084 AND PRO-4215, CHARACTERIZATION OF VARIANTS CMD1G MET-54 AND
RP   VAL-743, AND FUNCTION.
RX   PubMed=11846417; DOI=10.1006/bbrc.2002.6448;
RA   Itoh-Satoh M., Hayashi T., Nishi H., Koga Y., Arimura T., Koyanagi T.,
RA   Takahashi M., Hohda S., Ueda K., Nouchi T., Hiroe M., Marumo F.,
RA   Imaizumi T., Yasunami M., Kimura A.;
RT   "Titin mutations as the molecular basis for dilated cardiomyopathy.";
RL   Biochem. Biophys. Res. Commun. 291:385-393(2002).
RN   [34]
RP   VARIANT CMD1G ARG-976.
RX   PubMed=11788824; DOI=10.1038/ng815;
RA   Gerull B., Gramlich M., Atherton J., McNabb M., Trombitas K.,
RA   Sasse-Klaassen S., Seidman J.G., Seidman C., Granzier H., Labeit S.,
RA   Frenneaux M., Thierfelder L.;
RT   "Mutations of TTN, encoding the giant muscle filament titin, cause familial
RT   dilated cardiomyopathy.";
RL   Nat. Genet. 30:201-204(2002).
RN   [35]
RP   VARIANT TMD ASN-34306.
RX   PubMed=12891679; DOI=10.1002/ana.10647;
RA   Van den Bergh P.Y.K., Bouquiaux O., Verellen C., Marchand S., Richard I.,
RA   Hackman P., Udd B.;
RT   "Tibial muscular dystrophy in a Belgian family.";
RL   Ann. Neurol. 54:248-251(2003).
RN   [36]
RP   VARIANT CMD1G GLN-32996.
RX   PubMed=16465475; DOI=10.1007/s10974-005-9018-5;
RA   Matsumoto Y., Hayashi T., Inagaki N., Takahashi M., Hiroi S., Nakamura T.,
RA   Arimura T., Nakamura K., Ashizawa N., Yasunami M., Ohe T., Yano K.,
RA   Kimura A.;
RT   "Functional analysis of titin/connectin N2-B mutations found in
RT   cardiomyopathy.";
RL   J. Muscle Res. Cell Motil. 26:367-374(2005).
RN   [37]
RP   VARIANT MFM9 TRP-279, CHARACTERIZATION OF VARIANT MFM9 TRP-279, AND
RP   INTERACTION WITH NBR1.
RX   PubMed=15802564; DOI=10.1126/science.1110463;
RA   Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E.,
RA   Kristensen J., Brandmeier B., Franzen G., Hedberg B., Gunnarsson L.G.,
RA   Hughes S.M., Marchand S., Sejersen T., Richard I., Edstroem L., Ehler E.,
RA   Udd B., Gautel M.;
RT   "The kinase domain of titin controls muscle gene expression and protein
RT   turnover.";
RL   Science 308:1599-1603(2005).
RN   [38]
RP   INVOLVEMENT IN SALMY.
RX   PubMed=17444505; DOI=10.1002/ana.21089;
RA   Carmignac V., Salih M.A.M., Quijano-Roy S., Marchand S., Al Rayess M.M.,
RA   Mukhtar M.M., Urtizberea J.A., Labeit S., Guicheney P., Leturcq F.,
RA   Gautel M., Fardeau M., Campbell K.P., Richard I., Estournet B.,
RA   Ferreiro A.;
RT   "C-terminal titin deletions cause a novel early-onset myopathy with fatal
RT   cardiomyopathy.";
RL   Ann. Neurol. 61:340-351(2007).
RN   [39]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-60; MET-115; CYS-328; THR-360; ILE-498;
RP   MET-799; ILE-811; HIS-922; ASP-937; THR-1081; ARG-1137; GLU-1201; ALA-1202;
RP   LEU-1295; ASP-1345; THR-1347; HIS-1350; LEU-1353; VAL-1393; CYS-1416;
RP   PRO-1441; VAL-1544; GLN-1572; GLY-1658; GLN-1664; ASP-1692; LEU-1744;
RP   GLY-1772; ILE-1907; HIS-1998; LEU-2107; THR-2118; THR-2164; TYR-2240;
RP   SER-2392; PHE-2432; ILE-2610; MET-2771; PHE-2823; ASN-2831; ILE-2930;
RP   ARG-3154; GLU-3191; LEU-3238; GLY-3250; MET-3261; GLN-3367; LYS-3482;
RP   LYS-3570; VAL-3590; VAL-3762; PHE-3877; LEU-3965; PRO-4215; TRP-4238;
RP   PHE-4283; THR-4291; ASP-4303; GLU-4427; GLU-12310; ALA-12469; CYS-12642;
RP   LYS-12657; GLU-12679; PHE-12720; CYS-12798; GLY-13049; LYS-13083;
RP   LEU-13096; ARG-13099; ALA-13297; MET-13399; THR-13418; VAL-13428;
RP   THR-13430; LYS-13434; ASN-13469; ASN-13495; SER-13785; HIS-13870;
RP   ILE-14109; GLN-14131; THR-14208; VAL-14728; THR-14999; THR-15021;
RP   VAL-15520; ILE-15555; GLN-15620; ILE-15629; CYS-15635; GLN-15700;
RP   PRO-15705; MET-15837; HIS-16058; ILE-16067; THR-16090; HIS-16195;
RP   CYS-16409; PRO-16424; MET-16629; ARG-16877; ASP-17060; VAL-17637;
RP   HIS-17838; ASN-17866; GLU-17906; ALA-18094; SER-18109; THR-18164;
RP   LEU-18221; THR-18222; GLN-18726; ALA-18835; LYS-18881; SER-18939;
RP   GLN-19000; GLN-19060; LYS-19091; SER-19224; ILE-19367; LYS-19392;
RP   SER-19480; GLY-19495; HIS-19665; ILE-19762; ARG-19947; MET-19956;
RP   GLN-19992; CYS-20057; LEU-20075; LYS-20179; THR-20198; VAL-20198;
RP   HIS-20331; THR-20408; LYS-20564; ILE-20718; PRO-20726; ASN-20892;
RP   ARG-20894; GLU-21125; SER-21403; CYS-21730; GLN-21747; ARG-21851;
RP   ARG-21851; ARG-21925; HIS-21995; VAL-22045; HIS-22149; ILE-22160;
RP   THR-22261; ASN-22306; HIS-22357; PRO-22408; HIS-22537; LEU-22584;
RP   PRO-22646; ALA-22670; ASP-22770; THR-22801; TRP-22823; GLN-22968;
RP   LEU-23074; PHE-23079; ASN-23282; TYR-23303; CYS-23306; SER-23515;
RP   GLN-23551; ASN-23807; ASN-23872; ALA-23891; HIS-23933; MET-23939;
RP   LEU-23952; GLY-24098; SER-24119; ILE-24133; ALA-24159; ALA-24239;
RP   LYS-24265; THR-24584; THR-24781; HIS-24799; HIS-24954; MET-24980;
RP   HIS-25659; THR-25679; ALA-25720; LYS-25821; LYS-25859; LYS-25879;
RP   VAL-25923; ILE-26045; GLU-26059; VAL-26134; CYS-26477; TYR-26843;
RP   ARG-27346; CYS-27652; VAL-27728; LEU-27754; THR-27755; VAL-27929;
RP   LEU-28132; GLN-28168; HIS-28538; THR-28572; THR-28948; VAL-28986;
RP   GLU-28993; VAL-28998; MET-29070; VAL-29090; CYS-29419; PRO-29479;
RP   LEU-29880; GLU-29976; GLY-30042; CYS-30107; PHE-30125; PRO-30211;
RP   THR-30412; SER-30617; ILE-30674; ILE-30809; ILE-30818; LYS-30825;
RP   THR-30856; ASP-30887; SER-30887; HIS-30897; HIS-30907; HIS-30946;
RP   PHE-31081; CYS-31107; GLY-31124; SER-31156; THR-31246; HIS-31330;
RP   ARG-31690; GLN-31724; ILE-31725; SER-31732; ILE-31886; CYS-32097;
RP   ASN-32171; ILE-32248; HIS-32281; HIS-32323; TRP-32411; VAL-32558;
RP   VAL-32610; VAL-32637; ALA-32922; ARG-32943; HIS-32953; LEU-33213;
RP   CYS-33242; MET-33387; ASP-33419; MET-33536; GLN-33568; LYS-33616;
RP   LEU-33620; VAL-33886; THR-33899; PRO-33904; ILE-33955 AND ALA-34115.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [40]
RP   VARIANTS VAL-16046 AND GLN-32742.
RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,
RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,
RA   Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [41]
RP   VARIANTS PRO-2963 AND GLN-14750.
RX   PubMed=25173926; DOI=10.1161/circgenetics.113.000486;
RA   Girolami F., Iascone M., Tomberli B., Bardi S., Benelli M., Marseglia G.,
RA   Pescucci C., Pezzoli L., Sana M.E., Basso C., Marziliano N., Merlini P.A.,
RA   Fornaro A., Cecchi F., Torricelli F., Olivotto I.;
RT   "Novel alpha-actinin 2 variant associated with familial hypertrophic
RT   cardiomyopathy and juvenile atrial arrhythmias: a massively parallel
RT   sequencing study.";
RL   Circ. Cardiovasc. Genet. 7:741-750(2014).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=13;
CC         Comment=A number of isoforms may be produced, ranging from 27000 to
CC         33000 residues in different striated muscle tissues, the size of the
CC         full-length protein may be up to 38138 residues.;
CC       Name=1;
CC         IsoId=Q8WZ42-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WZ42-2; Sequence=VSP_019138;
CC       Name=3; Synonyms=Small cardiac N2-B;
CC         IsoId=Q8WZ42-3; Sequence=VSP_019139, VSP_019145;
CC       Name=4; Synonyms=Soleus;
CC         IsoId=Q8WZ42-4; Sequence=VSP_019142, VSP_019151;
CC       Name=5;
CC         IsoId=Q8WZ42-5; Sequence=VSP_019147, VSP_019148, VSP_019149,
CC                                  VSP_019150, VSP_019152;
CC       Name=6; Synonyms=Small cardiac novex-3;
CC         IsoId=Q8WZ42-6; Sequence=VSP_019143, VSP_019146;
CC       Name=7; Synonyms=Cardiac novex-2;
CC         IsoId=Q8WZ42-7; Sequence=VSP_019141, VSP_019144;
CC       Name=8; Synonyms=Cardiac novex-1;
CC         IsoId=Q8WZ42-8; Sequence=VSP_019140;
CC       Name=9;
CC         IsoId=Q8WZ42-9; Sequence=VSP_019139, VSP_042903, VSP_019145;
CC       Name=10;
CC         IsoId=Q8WZ42-10; Sequence=VSP_019139, VSP_019140, VSP_019145;
CC       Name=11;
CC         IsoId=Q8WZ42-11; Sequence=VSP_019142;
CC       Name=12;
CC         IsoId=Q8WZ42-12; Sequence=VSP_045935, VSP_045929, VSP_045930,
CC                                   VSP_045931, VSP_045932, VSP_045933,
CC                                   VSP_045934;
CC       Name=13;
CC         IsoId=Q8WZ42-13; Sequence=VSP_047142;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS33337.1; -.
DR   RefSeq; NP_596870.2; NM_133379.4.
DR   ProteomicsDB; 75216; -.
DR   Ensembl; ENST00000360870.10; ENSP00000354117.4; ENSG00000155657.29.
DR   Proteomes; UP000005640; Chromosome 2.
PE   1: Evidence at protein level;
FT   CONFLICT        3732
FT                   /note="L -> F (in Ref. 3; CAD12457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        5139
FT                   /note="R -> M (in Ref. 3; CAD12457)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   5604 AA;  631567 MW;  95DCBFC183B0C668 CRC64;
     MTTQAPTFTQ PLQSVVVLEG STATFEAHIS GFPVPEVSWF RDGQVISTST LPGVQISFSD
     GRAKLTIPAV TKANSGRYSL KATNGSGQAT STAELLVKAE TAPPNFVQRL QSMTVRQGSQ
     VRLQVRVTGI PTPVVKFYRD GAEIQSSLDF QISQEGDLYS LLIAEAYPED SGTYSVNATN
     SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR IEKKIEAHFD ARSIATVEMV
     IDGAAGQQLP HKTPPRIPPK PKSRSPTPPS IAAKAQLARQ QSPSPIRHSP SPVRHVRAPT
     PSPVRSVSPA ARISTSPIRS VRSPLLMRKT QASTVATGPE VPPPWKQEGY VASSSEAEMR
     ETTLTTSTQI RTEERWEGRY GVQEQVTISG AAGAAASVSA SASYAAEAVA TGAKEVKQDA
     DKSAAVATVV AAVDMARVRE PVISAVEQTA QRTTTTAVHI QPAQEQVRKE AEKTAVTKVV
     VAADKAKEQE LKSRTKEVIT TKQEQMHVTH EQIRKETEKT FVPKVVISAA KAKEQETRIS
     EEITKKQKQV TQEAIRQETE ITAASMVVVA TAKSTKLETV PGAQEETTTQ QDQMHLSYEK
     IMKETRKTVV PKVIVATPKV KEQDLVSRGR EGITTKREQV QITQEKMRKE AEKTALSTIA
     VATAKAKEQE TILRTRETMA TRQEQIQVTH GKVDVGKKAE AVATVVAAVD QARVREPREP
     GHLEESYAQQ TTLEYGYKER ISAAKVAEPP QRPASEPHVV PKAVKPRVIQ APSETHIKTT
     DQKGMHISSQ IKKTTDLTTE RLVHVDKRPR TASPHFTVSK ISVPKTEHGY EASIAGSAIA
     TLQKELSATS SAQKITKSVK APTVKPSETR VRAEPTPLPQ FPFADTPDTY KSEAGVEVKK
     EVGVSITGTT VREERFEVLH GREAKVTETA RVPAPVEIPV TPPTLVSGLK NVTVIEGESV
     TLECHISGYP SPTVTWYRED YQIESSIDFQ ITFQSGIARL MIREAFAEDS GRFTCSAVNE
     AGTVSTSCYL AVQVSEEFEK ETTAVTEKFT TEEKRFVESR DVVMTDTSLT EEQAGPGEPA
     APYFITKPVV QKLVEGGSVV FGCQVGGNPK PHVYWKKSGV PLTTGYRYKV SYNKQTGECK
     LVISMTFADD AGEYTIVVRN KHGETSASAS LLEEADYELL MKSQQEMLYQ TQVTAFVQEP
     KVGETAPGFV YSEYEKEYEK EQALIRKKMA KDTVVVRTYV EDQEFHISSF EERLIKEIEY
     RIIKTTLEEL LEEDGEEKMA VDISESEAVE SGFDSRIKNY RILEGMGVTF HCKMSGYPLP
     KIAWYKDGKR IKHGERYQMD FLQDGRASLR IPVVLPEDEG IYTAFASNIK GNAICSGKLY
     VEPAAPLGAP TYIPTLEPVS RIRSLSPRSV SRSPIRMSPA RMSPARMSPA RMSPARMSPG
     RRLEETDESQ LERLYKPVFV LKPVSFKCLE GQTARFDLKV VGRPMPETFW FHDGQQIVND
     YTHKVVIKED GTQSLIIVPA TPSDSGEWTV VAQNRAGRSS ISVILTVEAV EHQVKPMFVE
     KLKNVNIKEG SRLEMKVRAT GNPNPDIVWL KNSDIIVPHK YPKIRIEGTK GEAALKIDST
     VSQDSAWYTA TAINKAGRDT TRCKVNVEVE FAEPEPERKL IIPRGTYRAK EIAAPELEPL
     HLRYGQEQWE EGDLYDKEKQ QKPFFKKKLT SLRLKRFGPA HFECRLTPIG DPTMVVEWLH
     DGKPLEAANR LRMINEFGYC SLDYGVAYSR DSGIITCRAT NKYGTDHTSA TLIVKDEKSL
     VEESQLPEGR KGLQRIEELE RMAHEGALTG VTTDQKEKQK PDIVLYPEPV RVLEGETARF
     RCRVTGYPQP KVNWYLNGQL IRKSKRFRVR YDGIHYLDIV DCKSYDTGEV KVTAENPEGV
     IEHKVKLEIQ QREDFRSVLR RAPEPRPEFH VHEPGKLQFE VQKVDRPVDT TETKEVVKLK
     RAERITHEKV PEESEELRSK FKRRTEEGYY EAITAVELKS RKKDESYEEL LRKTKDELLH
     WTKELTEEEK KALAEEGKIT IPTFKPDKIE LSPSMEAPKI FERIQSQTVG QGSDAHFRVR
     VVGKPDPECE WYKNGVKIER SDRIYWYWPE DNVCELVIRD VTAEDSASIM VKAINIAGET
     SSHAFLLVQA KQLITFTQEL QDVVAKEKDT MATFECETSE PFVKVKWYKD GMEVHEGDKY
     RMHSDRKVHF LSILTIDTSD AEDYSCVLVE DENVKTTAKL IVEGAVVEFV KELQDIEVPE
     SYSGELECIV SPENIEGKWY HNDVELKSNG KYTITSRRGR QNLTVKDVTK EDQGEYSFVI
     DGKKTTCKLK MKPRPIAILQ GLSDQKVCEG DIVQLEVKVS LESVEGVWMK DGQEVQPSDR
     VHIVIDKQSH MLLIEDMTKE DAGNYSFTIP ALGLSTSGRV SVYSVDVITP LKDVNVIEGT
     KAVLECKVSV PDVTSVKWYL NDEQIKPDDR VQAIVKGTKQ RLVINRTHAS DEGPYKLIVG
     RVETNCNLSV EKIKIIRGLR DLTCTETQNV VFEVELSHSG IDVLWNFKDK EIKPSSKYKI
     EAHGKIYKLT VLNMMKDDEG KYTFYAGENM TSGKLTVAGG AISKPLTDQT VAESQEAVFE
     CEVANPDSKG EWLRDGKHLP LTNNIRSESD GHKRRLIIAA TKLDDIGEYT YKVATSKTSA
     KLKVEAVKIK KTLKNLTVTE TQDAVFTVEL THPNVKGVQW IKNGVVLESN EKYAISVKGT
     IYSLRIKNCA IVDESVYGFR LGRLGASARL HVETVKIIKK PKDVTALENA TVAFEVSVSH
     DTVPVKWFHK SVEIKPSDKH RLVSERKVHK LMLQNISPSD AGEYTAVVGQ LECKAKLFVE
     TLHITKTMKN IEVPETKTAS FECEVSHFNV PSMWLKNGVE IEMSEKFKIV VQGKLHQLII
     MNTSTEDSAE YTFVCGNDQV SATLTVTPIM ITSMLKDINA EEKDTITFEV TVNYEGISYK
     WLKNGVEIKS TDKCQMRTKK LTHSLNIRNV HFGDAADYTF VAGKATSTAT LYVEARHIEF
     RKHIKDIKVL EKKRAMFECE VSEPDITVQW MKDDQELQIT DRIKIQKEKY VHRLLIPSTR
     MSDAGKYTVV AGGNVSTAKL FVEGRDVRIR SIKKEVQVIE KQRAVVEFEV NEDDVDAHWY
     KDGIEINFQV QERHKYVVER RIHRMFISET RQSDAGEYTF VAGRNRSSVT LYVNAPEPPQ
     VLQELQPVTV QSGKPARFCA VISGRPQPKI SWYKEEQLLS TGFKCKFLHD GQEYTLLLIE
     AFPEDAAVYT CEAKNDYGVA TTSASLSVEV PEVVSPDQEM PVYPPAIITP LQDTVTSEGQ
     PARFQCRVSG TDLKVSWYSK DKKIKPSRFF RMTQFEDTYQ LEIAEAYPED EGTYTFVASN
     AVGQVSSTAN LSLEAPESIL HERIEQEIEM EMKELFSEGE SEHSERDTRD AFSDSEDIDH
     KSMAAKRYAS RISSTSSWPE YFKPSFTQKL TFKYVLEGEP VVFTCRLIAC PTPEMTWFHN
     NRPIPTGLRR IIKAESDLHH HSSSLEIKRV QDRDSGSYRL LAINSEGSAE STASLLVIQK
     GQDEKYLEFL KRAERTHENV EALVERGEDR IKVDLRFTGS PFNKKQDVEQ KGMMRTIHFK
     TMSSAKKTDY MYDEEYLESK SDIRGWLNVG ESFLDKETKV KLQRLREARK TLMEKKKLSL
     LDTSSEISSR TLRSEASDKD ILFSREDMKI RSMSDLAESY KVDHSAESIV QNPHALSNQM
     DQNIESEELP TSFQTIVDEE IFQTEIRMSQ EALVKESLPK DHLYGEILVN ENTQARGQLE
     EIMANTTIGE SSTYITNVCE KEEVYETPEN VSQAITPHAS ESFGTLVNVE ESEEIASERI
     KKDDLRELQL SASTRIDEFK TEQKEENMRF FENSFRKRPQ RCPPSFLQEI ESQEVYEGDS
     CNFVCHFQGY PQPIVTWYNN DMPIPRNQNF IIHSLENYSI LTLSSVHHQN EGSITCVLFN
     QYGTVKTTSM LKVKAKQKHD VKAHKVPVFH DYLDEEEELA LVFDQAKGAH PSMSQEGQTN
     LHLLKTNPPV PPSGDTELLS FPVEIQVTAA TPIPEQDKES KEVFQTEELE PKAMPQDQVT
     QSPKHRFVFL SDITNEPPKM LQEMPKHARC REGDSIILEC LISGEPQPVV TWFQNGVLLK
     QNQKFQFEEV NCSHQLYIKD VNSQDSGKYK CVAENNSGAV ESVSDLTVEP VTYRENSQFE
     NIGEIYGKYS RDQQLQDQGE SVRAHFYDYP AGPFTPWTNV KEYSVRDYFQ SLETIEQIDQ
     KEQVRCIPSR EKIPRFVHGA SRTIKISKPI RAEFIQCQAE GKERHVSEKS KLHQAEGTVY
     PFVDDFSDVT IKKEIRNNFG KLGRSEKENV QECAQSDYLP NIHSERISDS YNTKDSSAIV
     YEESLGEEIH YPGKKVKHRI IEFEKLHVEK GVLEKRPTRT SIVNPPQKKI DDKAFSLKQR
     ESRSSNLNAN MYQAEKMSPN TESDSSNIAI NLKLLSSQTH KEFDAQEREQ QEKISLIDKP
     AISKRAEHES PITFDLKQFH TQIKHTDVKF QELDSGQPEE AYFKIQHPAD TENIVFDLKQ
     MYSHIGDPAL EFQGQETREQ QEIHYKEKIP SPETLQPDTH NISKSVQNNV FASQEISSSQ
     ELSNRTMVEK SSIDENSISL EKEVRHVQEQ NLDILKTDLS LKSFSEEIYS ESCALLPTSS
     ADIEETDLSE KSCPLENGGR SSISHLKKAA SEEKPLGVGE MEEECTLEPE LAAFPKQDGG
     TQEYTDATLE DHRGDVQEAD TLHRQLSLSQ CFPLLMTEEQ QNPGEQISTN IHASGEEKCY
     EEVQVQNEAS FSTLEGEMIE TSFSQNIPKL DEAHTTEAAE SETSLTQYLL AAGKREVPET
     KDTRDQAKLV QSESITSMEV EEVTFNTVYE YYNQKQESLG RPLSPESDIS IGVGSTTSEE
     ISELDQFYTP PSSVEYFESP KSPDLYFNPS DITKQSSIHS GGETVERYST PLGEVAERYS
     TPSEGEVGER YSTPPGETLE RYSTPPGETL ERYSTPPGET LERYSTPPGE TLERYSTPPG
     ETLERYSTPP GEALERYSIP TGGPNPTGTF KTYPSKIERE DGTPNEHFYT PTEERGSAYE
     IWRSDSFGTP NEAIEPKDNE MPPSFIEPLT KRKVYENTTL GFIVEVEGLP VPGVKWYRNK
     SLLEPDERIK MERVGNVCSL EISNIQKGEG GEYMCHAVNI IGEAKSFANV DIMPQEERVV
     ALPPPVTHQH VMEFDLEHTT SSRTPSPQEI VLEVELSEKD VKEFEKQVKI VTVPEFTPDH
     KSMIVSLDVL PFNFVDPNMD SREGEDKELK IDLEVFEMPP RFIMPICDFK IPENSDAVFK
     CSVIGIPTPE VKWYKEYMCI EPDNIKYVIS EEKGSHTLKI RNVCLSDSAT YRCRAVNCVG
     EAICRGFLTM GDSEIFAVIA KKSKVTLSSL MEELVLKSNY TDSFFEFQVV EGPPRFIKGI
     SDCYAPIGTA AYFQCLVRGS PRPTVYWYKD GKLVQGRRFT VEESGTGFHN LFITSLVKSD
     EGEYRCVATN KSGMAESFAA LTLT
//
